[Skip to Content]
[Skip to Content Landing]
March 7, 1908


JAMA. 1908;L(10):773. doi:10.1001/jama.1908.02530360035007

The notable articles by Henius and by His, full abstracts of which appear in this issue of The Journal,1 merit careful consideration not only by physicians, but also by druggists and by drug manufacturers. These articles give a vivid and instructive picture of the conditions that in Germany have led to persistent efforts to secure adequate control of the intolerable and harmful commercial exploitation of new drugs and of proprietaries of all kinds. It is quite evident that work like that undertaken by the Council on Pharmacy and Chemistry of the American Medical Association is just as necessary in Germany to-day as it is in our own country. No doubt this is true also in regard to practically all other countries. His covers the ground well when he says that there are houses which strive to make money out of old familiar drugs by new combinations and a catchy

First Page Preview View Large
First page PDF preview
First page PDF preview